Charles River Laboratories (CRL) Tops Q4 EPS by 4c

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $280.1 million versus the consensus estimate of $280.81 million.

Charles River Laboratories reaffirmed FY2013 guidance.

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
• TiVo, Inc. (TIVO) Tops Q1 EPS by 6c; Issues Solid Q2 Rev Outlook
• UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?